Cantitate/Preț
Produs
Total produse
Vezi coșul
Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume One, Compressed Solid Products de Sarfaraz K. Niazi

Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume One, Compressed Solid Products

Autor Sarfaraz K. Niazi
en Limba Engleză Hardback – 14 noi 2019
The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume One, Compressed Solid Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this first volume of a six-volume set, compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (7) 30276 lei  6-8 săpt.
  CRC Press – 31 oct 2024 316390 lei  3-5 săpt.
  CRC Press – 14 oct 2024 30276 lei  6-8 săpt.
  CRC Press – 14 oct 2024 30276 lei  6-8 săpt.
  CRC Press – 14 oct 2024 30276 lei  6-8 săpt.
  CRC Press – 14 oct 2024 30276 lei  6-8 săpt.
  CRC Press – 14 oct 2024 30454 lei  6-8 săpt.
  CRC Press – 14 oct 2024 30789 lei  6-8 săpt.
Hardback (7) 137575 lei  6-8 săpt.
  CRC Press – 21 noi 2019 137575 lei  6-8 săpt.
  CRC Press – 17 dec 2019 137584 lei  6-8 săpt.
  CRC Press – 17 dec 2019 137603 lei  6-8 săpt.
  CRC Press – 20 noi 2019 137690 lei  6-8 săpt.
  CRC Press – 17 dec 2019 137799 lei  6-8 săpt.
  CRC Press – 14 noi 2019 138373 lei  6-8 săpt.
  CRC Press – 17 dec 2019 554738 lei  6-8 săpt.

Preț: 138373 lei

Preț vechi: 168119 lei
-18% Nou

Puncte Express: 2076
Preț estimativ în valută:
26482€ • 27935$ • 22132£

Carte tipărită la comandă

Livrare economică 31 decembrie 24 - 14 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781138102804
ISBN-10: 1138102806
Pagini: 592
Dimensiuni: 210 x 280 x 43 mm
Greutate: 1.71 kg
Ediția:3
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Public țintă

Academic

Cuprins

Part I Regulatory and Manufacturing Considerations
Chapter 1: Bioequivalence Testing: Rationale and Principle
Chapter 2: Guidance for Industry
Chapter 3: Product-Specific Guidance from FDA on the Development of Compressed Dosage Forms
Chapter 4: Guidance on Formulating Compressed Solids
Part II Manufacturing Formulations
Part III Tablet Coating Formulations
Part IV Composition of Proprietary Products Approved in the United States

Notă biografică

Sarfaraz K. Niazi, Ph.D a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines. He is Founder and Executive Chairman of Adello Biologics, LLC, (formerly, Therapeutic Proteins International, LLC), a biosimilar products company located in Chicago, IL, Piscataway, NJ and Cashel, Ireland. As an entrepreneur, Niazi has raised hundreds of millions of dollars and became recognized as an inductee into the Chicago Entrepreneur Hall of Fame.Niazi began his career teaching pharmaceutical sciences at the University of Illinois, College of Pharmacy where he was tenured before entering the industry at Abbott International. He departed Abbott as an Abbott Volwiler Fellow to pursue his passion, first through global consulting and later through the founding a biosimilar products company.
A prolific inventor with scores of patents, most prominently in the field of bioprocessing technology, Niazi is currently the largest single holder of bioprocess technology patents. His other inventions span a broad category of technologies, new chemical entities, new formulations, new analytical methodologies, and much more. He has hands on experience in developing chemical, botanical and biological products, from discovery to regulatory approval. With over 50 ISBNs under his name, Niazi has authored many landmark books in the field of pharmaceutical sciences.
He currently serves as Adjunct Professor at the University of Illinois College of Pharmacy, Ad Hoc faculty at the University of Houston, Texas, the HEJ Research Institute, Karachi, and the National University of Science and Technology, Islamabad. He has also served as a Foreign Professor at the HEJ Research Institute, Karachi. He serves on the editorial board of the journal MOJ Proteomics & Bioinformatics (MOJPB) and starting 2017, as Chief Editor of International Journal of Biosimilars. He also serves as Member of National Advisory Board of the College of Pharmacy, University of Illinois. He is a Fellow of the Pakistan Academy of Medical Sciences, Fellow National Academy of Clinical Biochemistry and Institute of Biology. He served as a TOKTEN Fellow to India (Transfer of Knowledge Through Expatriate Nationals (UNDP). In 2013, he received the one of the highest civilian awards, Star of Distinction in Engineering, from the Pakistani President. He has hosted a radio show at Voice of America (US State Department) on a weekly basis for more than 5 years with audience into billions.

Recenzii

This six-volume comprehensive handbook is a widely known reference in the field, and the third edition provides an up-to-date overview of the area of pharmaceutical manufacturing formulations. The current edition has greatly improved the previous edition, presenting all aspects related to state-of-the-art pharmaceutical manufacturing formulations.
-Marc A Ilies, PhD, Temple University School of Pharmacy

Descriere

The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume One, Compressed Solid Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this first volume of a six-volume set, compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent.